Duration of third stage labour and postpartum blood loss: a secondary analysis of the WHO CHAMPION trial data

• Autores: Chikkamath, Sumangala B.; Katageri, Geetanjali M.; Mallapur, Ashalata A.; Vernekar, Sunil S.; Somannavar, Manjunath S.; Piaggio, Gilda; Carroli, Guillermo; de Carvalho, José Ferreira; Althabe, Fernando; Hofmeyr, G. Justus; Widmer, Mariana; Gulmezoglu, Ahmet Metin; Goudar, Shivaprasad S.
• Año de publicación: 2021
• Idioma: inglés
• Tipo de recurso: artículo
• Materia: DURATION; HEAT-STABLE CARBETOCIN; OXYTOCIN; POSTPARTUM BLOOD LOSS; THIRD STAGE OF LABOUR; UTEROTONICS
• Institución: Consejo Nacional de Investigaciones Científicas y Técnicas

Background: Obstetric haemorrhage continues to be a leading cause of maternal mortality, contributing to more than a quarter of the 2,443,000 maternal deaths reported between 2003 and 2009. During this period, about 70% of the haemorrhagic deaths occurred postpartum. In addition to other identifiable risk factors for greater postpartum blood loss, the duration of the third stage of labour (TSL) seems to be important, as literature shows that a longer TSL can be associated with more blood loss. To better describe the association between the duration of TSL and postpartum blood loss in women receiving active management of third stage of labour (AMTSL), this secondary analysis of the WHO CHAMPION trial data has been conducted. Methods: This was a secondary analysis of the WHO CHAMPION trial conducted in twenty-three sites in ten countries. We studied the association between the TSL duration and blood loss in the sub cohort of women from the CHAMPION trial (all of whom received AMTSL), with TSL upto 60 min and no interventions for postpartum haemorrhage. We used a general linear model to fit blood loss as a function of TSL duration on the log scale, arm and center, using a normal distribution and the log link function. We showed this association separately for oxytocin and for Heat stable (HS) carbetocin. Results: For the 10,040 women analysed, blood loss rose steeply with third stage duration in the first 10 min, but more slowly after 10 min. This trend was observed for both Oxytocin and HS carbetocin and the difference in the trends for both drugs was not statistically significant (p-value = 0.2070). Conclusions: There was a positive association between postpartum blood loss and TSL duration with either uterotonic. Blood loss rose steeply with TSL duration until 10 min, and more slowly after 10 min.
Fil: Chikkamath, Sumangala B.. S. Nijalingappa Medical College; India
Fil: Katageri, Geetanjali M.. S. Nijalingappa Medical College; India
Fil: Mallapur, Ashalata A.. S. Nijalingappa Medical College; India
Fil: Vernekar, Sunil S.. Jawaharlal Nehru Medical College Belgaum; India
Fil: Somannavar, Manjunath S.. Jawaharlal Nehru Medical College Belgaum; India
Fil: Piaggio, Gilda. No especifíca;
Fil: Carroli, Guillermo. Centro Rosarino de Estudios Perinatales; Argentina
Fil: de Carvalho, José Ferreira. No especifíca;
Fil: Althabe, Fernando. Organizacion Mundial de la Salud; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Hofmeyr, G. Justus. University of Botswana; Estados Unidos. University of the Witwatersrand; Sudáfrica
Fil: Widmer, Mariana. Organizacion Mundial de la Salud; Argentina
Fil: Gulmezoglu, Ahmet Metin. No especifíca;
Fil: Goudar, Shivaprasad S.. Jawaharlal Nehru Medical College Belgaum; India